Navco Pharmaceuticals (TSXV:NAV) Equity-to-Asset : 0.04 (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Navco Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2023 was C$0.00 Mil. Navco Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2023 was C$0.10 Mil.

The historical rank and industry rank for Navco Pharmaceuticals's Equity-to-Asset or its related term are showing as below:

TSXV:NAV' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.04 Med: 0.9 Max: 1
Current: 0.04

During the past 4 years, the highest Equity to Asset Ratio of Navco Pharmaceuticals was 1.00. The lowest was 0.04. And the median was 0.90.

TSXV:NAV's Equity-to-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.58 vs TSXV:NAV: 0.04

Navco Pharmaceuticals Equity-to-Asset Historical Data

The historical data trend for Navco Pharmaceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Equity-to-Asset Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Equity-to-Asset

1.00

0.91

0.89

0.84

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Equity-to-Asset	Get a 7-Day Free Trial														0.46	0.03	0.01	-0.04	0.04

Competitive Comparison of Navco Pharmaceuticals's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Navco Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navco Pharmaceuticals's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navco Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Navco Pharmaceuticals's Equity-to-Asset falls into.

Navco Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Navco Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Jun. 2021 is calculated as

Equity to Asset (A: Jun. 2021 )	=	Total Stockholders Equity	/	Total Assets
	=	0.097	/	0.116
	=

Navco Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

Equity to Asset (Q: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0.004	/	0.095
	=

Navco Pharmaceuticals (TSXV:NAV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Navco Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.